 |
市場調査レポート
商品コード
1448342
局所麻酔薬の世界市場規模、シェア、成長分析：製品別、用途別 - 産業予測（2024～2031年）Global Local Anesthesia Drugs Market Size, Share, Growth Analysis, By Product(Bupivacaine, Ropivacaine), By Application(Injectable, Surface Anesthetic) - Industry Forecast 2024-2031 |
||||||
| 局所麻酔薬の世界市場規模、シェア、成長分析：製品別、用途別 - 産業予測（2024～2031年） |
|
出版日: 2024年03月07日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の局所麻酔薬の市場規模は、2022年に43億4,000万米ドルとなり、2023年の44億9,000万米ドルから、2031年までには59億1,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは3.5%で成長する見通しです。
局所麻酔薬の世界市場には、医療処置中に身体の特定部位を一時的に麻痺させ、患者の痛みを和らげるために使用される医薬品が含まれます。これらの薬剤は、標的とする部位の神経信号を遮断することで作用し、不快感を与えることなく手術を行うことを可能にします。この市場は、侵襲性の低い手術に対する需要の増加、慢性疾患の疼痛管理を必要とする患者の増加、より優れた薬剤の処方などにより拡大しています。この市場の主要プレーヤーは、リドカイン、ブピバカインなど様々な麻酔薬を製造する製薬会社です。これらの薬剤は、処置や患者のニーズに応じて、注射、皮膚への塗布、吸入によって投与されます。高齢者の増加、病院外で行われる手術の増加、高度な医療器具などの要因も市場に影響を与えています。さらに、医薬品をカスタマイズする傾向があり、新しいタイプの薬剤や投与方法が生まれていることも、市場の成長を後押ししています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
局所麻酔薬の世界市場：製品別
- 市場概要
- ブピバカイン
- ロピバカイン
- リドカイン
- クロロプロカイン
- プリロカイン
- ベンゾカイン
- その他の局所麻酔薬
局所麻酔薬の世界市場：用途別
- 市場概要
- 注射剤
- 表面麻酔薬
局所麻酔薬の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Johnson & Johnson（USA）
- Pfizer Inc.（USA）
- AstraZeneca plc（UK）
- Novartis AG（Switzerland）
- Teva Pharmaceutical Industries Ltd.（Israel）
- GlaxoSmithKline plc（UK）
- Sanofi S.A.（France）
- Merck & Co., Inc.（USA）
- Aspen Pharmacare Holdings Limited（South Africa）
- Mylan N.V.（USA）
- Fresenius SE & Co. KGaA（Germany）
- Abbott Laboratories（USA）
- Baxter International Inc.（USA）
- Daiichi Sankyo Company, Limited（Japan）
- Mallinckrodt Pharmaceuticals（USA）
- Sun Pharmaceutical Industries Ltd.（India）
- Endo International plc（Ireland）
- Hikma Pharmaceuticals PLC（Jordan）
- Orion Corporation（Finland）
- Sandoz International GmbH（Germany）
- Wockhardt Ltd.（India）
- Mundipharma International Limited（UK）
- Perrigo Company plc（Ireland）
- Recordati S.p.A.（Italy）
- Piramal Enterprises Ltd.（India）
Global Local Anesthesia Drugs Market size was valued at USD 4.34 billion in 2022 and is poised to grow from USD 4.49 billion in 2023 to USD 5.91 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024- 2031).
The global market for local anesthesia drugs includes medicines used to temporarily numb specific parts of the body during medical procedures, easing pain for patients. These drugs work by blocking nerve signals in targeted areas, allowing surgeries to be done without causing discomfort. The market has grown due to the increasing demand for less invasive surgeries, more people needing pain management for chronic conditions, and better drug formulations. Major players in this market are pharmaceutical companies making various anesthetic drugs like lidocaine, bupivacaine, and others. These drugs can be given through injections, applied on the skin, or inhaled, depending on the procedure and patient's needs. Factors like more elderly people, more surgeries done outside hospitals, and advanced medical tools also affect the market. Additionally, there's a trend toward customizing medicines, leading to new types of drugs and how they're given, which helps the market grow.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Local Anesthesia Drugs Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Local Anesthesia Drugs Market Segmental Analysis
The global local anesthesia drugs market is segmented on the basis of Product, Application, and region. By Product, the market is segmented into Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other local anesthetics. By Application, the market is segmented into Injectable, Surface Anesthetic. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Local Anesthesia Drugs Market
The rise in surgical procedures, whether small or large, is a major factor pushing the local anesthesia drugs market forward. Local anesthesia is often used to numb a particular part of the body, lessening the need for general anesthesia and its potential risks. With advancements in surgical methods and the introduction of new procedures, there's a growing need for reliable local anesthesia drugs.
Restraints in the Global Local Anesthesia Drugs Market
The local anesthesia drugs market must meet strict rules and undergo thorough approval processes from health authorities. Creating and getting approval for new drugs or versions can take a lot of time and money. These regulatory obstacles may delay the launch of new products, which could hinder innovation and market expansion.
Market Trends of the Global Local Anesthesia Drugs Market
Local anesthesia drugs are frequently employed in a variety of medical procedures, particularly those that are minimally invasive. These procedures are becoming more popular because they offer advantages like quicker recovery, lower chances of complications, and reduced healthcare expenses. With ongoing technological progress making minimally invasive procedures safer and more feasible, the need for local anesthesia drugs to support these procedures is likely on the rise.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Local Anesthesia Drugs Market by Product
- Market Overview
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Prilocaine
- Benzocaine
- and Other local anesthetics
Global Local Anesthesia Drugs Market by Application
- Market Overview
- Injectable
- Surface Anesthetic
Global Local Anesthesia Drugs Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aspen Pharmacare Holdings Limited (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius SE & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mallinckrodt Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Endo International plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hikma Pharmaceuticals PLC (Jordan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orion Corporation (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sandoz International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wockhardt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mundipharma International Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Recordati S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Piramal Enterprises Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
